Factors Influencing Participation in COVID-19 Clinical Trials: A Multi-National Study
- 1Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt
- 2Epidemiology Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt
- 3Department of Basic Medical Sciences, Faculty of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia
- 4Office of Monitoring, Research, Learning and Evaluation, Tetra Tech DPK, Amman, Jordan
- 5Department of Research Labs, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia
- 6Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
- 7Department of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University, Cairo, Egypt
- 8Department of Physiology and Biochemistry, The University of Jordan, Amman, Jordan
A corrigendum on
Factors influencing participation in COVID-19 clinical trials: a multinational study
by Abdelhafiz, A. S., Abd ElHafeez, S., Khalil, M. A., Shahrouri, M., Alosaimi, B., Salem, R. O., Alorabi, M., Abdelgawad, F., and Ahram, M. (2021). Front. Med. 8:608959. doi: 10.3389/fmed.2021.608959
In the published article, an author name was incorrectly written as Bandar Alosaim. The correct spelling is Bandar Alosaimi.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: COVID-19, clinical trials, Arabs, bioethics, attitude
Citation: Abdelhafiz AS, Abd ElHafeez S, Khalil MA, Shahrouri M, Alosaimi B, Salem RO, Alorabi M, Abdelgawad F and Ahram M (2023) Corrigendum: Factors influencing participation in COVID-19 clinical trials: a multinational study. Front. Med. 10:1230259. doi: 10.3389/fmed.2023.1230259
Received: 12 June 2023; Accepted: 12 June 2023;
Published: 22 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Abdelhafiz, Abd ElHafeez, Khalil, Shahrouri, Alosaimi, Salem, Alorabi, Abdelgawad and Ahram. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mamoun Ahram, m.ahram@ju.edu.jo; dr.ahram@gmail.com